These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 17392714

  • 21. Androgen receptor regulates CD168 expression and signaling in prostate cancer.
    Lin SL, Chang D, Chiang A, Ying SY.
    Carcinogenesis; 2008 Feb; 29(2):282-90. PubMed ID: 18174258
    [Abstract] [Full Text] [Related]

  • 22. Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha.
    Buchanan G, Ricciardelli C, Harris JM, Prescott J, Yu ZC, Jia L, Butler LM, Marshall VR, Scher HI, Gerald WL, Coetzee GA, Tilley WD.
    Cancer Res; 2007 Oct 15; 67(20):10087-96. PubMed ID: 17942943
    [Abstract] [Full Text] [Related]

  • 23. Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence.
    D'Antonio JM, Ma C, Monzon FA, Pflug BR.
    Prostate; 2008 May 15; 68(7):698-714. PubMed ID: 18302219
    [Abstract] [Full Text] [Related]

  • 24. Targeting the androgen receptor in hormone-refractory prostate cancer--new concepts.
    Eder IE, Haag P, Bartsch G, Klocker H.
    Future Oncol; 2005 Feb 15; 1(1):93-101. PubMed ID: 16555979
    [Abstract] [Full Text] [Related]

  • 25. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.
    Lee SO, Dutt SS, Nadiminty N, Pinder E, Liao H, Gao AC.
    Prostate; 2007 Sep 01; 67(12):1293-300. PubMed ID: 17626246
    [Abstract] [Full Text] [Related]

  • 26. Regulation of androgen receptor signaling in prostate cancer.
    Dehm SM, Tindall DJ.
    Expert Rev Anticancer Ther; 2005 Feb 01; 5(1):63-74. PubMed ID: 15757439
    [Abstract] [Full Text] [Related]

  • 27. The androgen receptor in prostate cancer: therapy target in search of an integrated diagnostic test.
    Ross JS.
    Adv Anat Pathol; 2007 Sep 01; 14(5):353-7. PubMed ID: 17717436
    [Abstract] [Full Text] [Related]

  • 28. Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer.
    Nishiyama T, Suzuki K, Yamana K, Tonegawa E, Wako K, Takahashi K.
    Expert Rev Anticancer Ther; 2006 Feb 01; 6(2):259-68. PubMed ID: 16445378
    [Abstract] [Full Text] [Related]

  • 29. [Therapeutic implications of the revised concept of hormone-refractory metastatic prostate cancer].
    Paule B.
    Prog Urol; 2004 Dec 01; 14(6):1119-24. PubMed ID: 15751404
    [Abstract] [Full Text] [Related]

  • 30. Signal transduction in prostate cancer progression.
    Gioeli D.
    Clin Sci (Lond); 2005 Apr 01; 108(4):293-308. PubMed ID: 15603554
    [Abstract] [Full Text] [Related]

  • 31. Molecular alterations during progression of prostate cancer to androgen independence.
    Saraon P, Jarvi K, Diamandis EP.
    Clin Chem; 2011 Oct 01; 57(10):1366-75. PubMed ID: 21956922
    [Abstract] [Full Text] [Related]

  • 32. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor.
    Kraus S, Gioeli D, Vomastek T, Gordon V, Weber MJ.
    Cancer Res; 2006 Nov 15; 66(22):11047-54. PubMed ID: 17108144
    [Abstract] [Full Text] [Related]

  • 33. Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling.
    Mousses S, Wagner U, Chen Y, Kim JW, Bubendorf L, Bittner M, Pretlow T, Elkahloun AG, Trepel JB, Kallioniemi OP.
    Oncogene; 2001 Oct 11; 20(46):6718-23. PubMed ID: 11709706
    [Abstract] [Full Text] [Related]

  • 34. Novel therapeutic strategies for castration resistant prostate cancer: inhibition of persistent androgen production and androgen receptor mediated signaling.
    Molina A, Belldegrun A.
    J Urol; 2011 Mar 11; 185(3):787-94. PubMed ID: 21239012
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The androgen receptor gene and its influence on the development and progression of prostate cancer.
    Montgomery JS, Price DK, Figg WD.
    J Pathol; 2001 Sep 11; 195(2):138-46. PubMed ID: 11592091
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Expression of androgen receptor protein in hormone refractory prostate cancer].
    Zhang Y, Chen W, Hu XK, Gui ZN.
    Ai Zheng; 2003 Jan 11; 22(1):95-7. PubMed ID: 12561446
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.